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The use of CAR+ T cells for the treatment of cancer is
growing as multiple centers participate in Phase I/II
clinical trials. Prior studies of CAR-dependent T cell
effector function evaluated CAR design on T-cell
responses in vitro and in vivo. Our study assesses the
effect ex vivo co-stimulation imparts on in vitro and in
vivo effector function of CAR+ T cells. In this study, the
well characterized CD19-specific 2nd generation CAR,
signaling through CD28 and CD3-ζ endodomains, was
expressed in donor T cells. Non-virally transformed T
cells, induced to genomically integrate CAR by Sleeping
Beauty transposase, were numerically expanded on arti-
ficial antigen presenting cells (aAPC) derived from
K562. The aAPC were genetically modified to present
the target antigen CD19 along with no co-stimulation,
or co-stimulation via CD86, CD137L, or both molecules.
The addition of co-stimulation to the culture impacted
the expression of CAR and the phenotype of the CAR+
T cells. The co-expression of a second transgene, indu-
cible Caspase 9 (iC9) - a suicide gene, with CAR was
also affected by the choice of aAPC. Furthermore, the
anti-tumor activity of the CAR+ T cells numerically
expanded on aAPC with or without co-stimulation was
tested by adoptive transfer into mice containing CD19+
tumor. These data highlight that the use of co-stimula-
tion in the ex vivo culture could potentially impact the
therapeutic potential of CAR+ T cells.
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